Kips Bay Medical Provides FDA Update and Reports Second Quarter 2012 Results
Kips Bay Medical, Inc. today provides an FDA update and announces financial results for its second quarter ended June 30, 2012.

Watson's Generic Version of Pulmicort RESPULES Receives FDA Approval
PARSIPPANY, N.J., Aug. 1, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that its subsidiary Watson Laboratories, Inc., has received approval from the United States Food ...

pSivida Corp. Reports Alimera s Intention to Resubmit Application to FDA for ILUVIEN in DME Using Data from Completed ...
pSivida Corp. , a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today reported that its licensee Alimera Sciences, Inc.